Search

Displaying results 61 - 70 of 108 in total
  1. Drug

    Quaratusugene ozeplasmid

    go.drugbank.com/drugs/DB19231
    Investigational

    Quaratusugene ozeplasmid is under investigation in clinical trial NCT05062980 (Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-small Lung Cancer).

  2. Indication

    Locally Advanced Cutaneous Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0133965
    Drugs: Cemiplimab · Cosibelimab · Pembrolizumab
  3. Indication

    Unresectable Locally Advanced Triple-negative Breast Cancer

    go.drugbank.com/conditions/DBCOND0154926
    Drugs: Pembrolizumab · Sacituzumab govitecan
  4. Drug

    Atamparib

    go.drugbank.com/drugs/DB19028
    Investigational

    Atamparib is under investigation in clinical trial NCT05127590 (RBN-2397 in Combination With Pembrolizumab in Patients With SCCL).

  5. Drug

    Vactosertib

    go.drugbank.com/drugs/DB15310
    Investigational

    Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).

  6. Drug

    Toll-like receptor 9

    go.drugbank.com/drugs/DB15320
    Investigational

    Toll-like receptor 9 is under investigation in clinical trial NCT03007732 (Pembrolizumab in Combination With Intratumoral SD-101 Therapy).

  7. Drug

    CXD101

    go.drugbank.com/drugs/DB16182
    Investigational

    CXD101 is under investigation in clinical trial NCT03873025 (A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-cell Lymphoma).

  8. Drug

    LY-3200882

    go.drugbank.com/drugs/DB16064
    Investigational

    LY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer).

  9. Indication

    Refractory Primary Mediastinal Large B-Cell Cell Lymphoma

    go.drugbank.com/conditions/DBCOND0135857
    Drugs: Epcoritamab · Lisocabtagene maraleucel · Pembrolizumab
  10. Indication

    Metastatic Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0046438
    Drugs: Durvalumab · Pembrolizumab · Zanidatamab